News

Adequan® in the News



OCTOBER, 2021
1
OCT
Celebrate the 2021 PATH Intl. Veterinarian Award Winners
Denver, CO – October 1, 2021 – The Professional Association of Therapeutic Horsemanship (PATH Intl.) takes great pride in the exceptional veterinarians who serve at PATH Intl. Member Centers and the quality of life for the equines that partner with humans in equine-assisted services (EAS). PATH Intl. is pleased to announce the 2021 PATH Intl. Veterinarian Award in its 11 regions and the national award winner, sponsored by American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan). We thank American Regent Animal Health for the way they have supported our centers and the equines that are at the heart of EAS.

Celebrate the 2021 PATH Intl. Veterinarian Award Winners

Denver, CO – October 1, 2021 - The Professional Association of Therapeutic Horsemanship (PATH Intl.) takes great pride in the exceptional veterinarians who serve at PATH Intl. Member Centers and the quality of life for the equines that partner with humans in equine-assisted services (EAS). PATH Intl. is pleased to announce the 2021 PATH Intl. Veterinarian Award in its 11 regions and the national award winner, sponsored by American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan). We thank American Regent Animal Health for the way they have supported our centers and the equines that are at the heart of EAS.

In previous years, PATH Intl. has celebrated the region winners at regional conferences and the national winners at the PATH Intl. Conference awards luncheon. Although this year the national conference has been postponed, the winners of these awards deserve recognition of their achievements. PATH Intl. and American Regent Animal Health, maker of Adequan® i.m., offer their congratulations and accolades to these winners.

(PATH Intl. Premier Accredited Centers are shown in italics.)

2021 PATH Intl. Regional Winners

Dr. Christopher Weber

Region 1
Veterinarian of the Year, Dr. Christopher Weber, Shepard Meadows Therapeutic Riding Center, Inc., Bristol, CT

Region 1 includes the following states: Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island and Vermont; and the Canadian provinces: New Brunswick, Newfoundland, Nova Scotia, Prince Edward Island and Quebec

Dr. Jesslyn Bryk-Lucy

Region 2
Veterinarian of the Year, Dr. Jesslyn Bryk-Lucy, Therapeutic Riding at Centenary - TRAC, Hackettstown, NJ

Region 2 includes the following states: Delaware, Maryland, New Jersey, New York Pennsylvania and Washington, DC; and Scandinavia, Europe, Middle East

Dr. Lauren Taylor

Region 3
Veterinarian of the Year, Dr. Lauren Taylor, Moonbeam and Miracles Therapeutic Horsemanship Center, Greenville, NC

Region 3 includes the following states: North Carolina, South Carolina, Virginia and West Virginia

Bluegrass Equine Podiatry

Region 4
Veterinarian of the Year, Bluegrass Equine Podiatry, Central Kentucky Riding for Hope, Lexington, KY

Region 4 includes the following states: Indiana, Kentucky Michigan and Ohio; and the Canadian Province of Ontario

Dr. Hugh Worsham

Region 5
Veterinarian of the Year, Dr. Hugh Worsham, Chastain Horse Park, Atlanta, GA

Region 5 includes the following states: Alabama, Florida, Georgia, Mississippi and Tennessee; and Puerto Rico and Africa

Fredonia Veterinarian Clinic

Region 6
Veterinarian of the Year, Fredonia Veterinarian Clinic, Heaven’s Gait Ranch, Inc., Cedar Grove, WI

Region 6 includes the following states: Minnesota, North Dakota, South Dakota and Wisconsin; and the Canadian Provinces of Manitoba and Saskatchewan

Region 7
Veterinarian of the Year, Dr. Kim Conover, Heartland Equine Therapeutic Riding Academy, Gretna, NE

Region 7 includes the following states: Illinois, Iowa, Kansas, Missouri and Nebraska

Dr. David Fazzino

Region 8
Veterinarian of the Year, Dr. David Fazzino, Grace Lake Ministries, Inc., Anna, TX

Region 8 includes the following states: Arkansas, Louisiana, Oklahoma and Texas; and Mexico, Central America and South America

Region 9
No winner selected

Region 9 includes the following states: Alaska, Idaho, Montana, Oregon and Washington state; and the Canadian provinces of Alberta and British Columbia

Dr. JD Leclair

Region 10
Veterinarian of the Year, Dr. JD Leclair, Hearts & Horses, Inc., Loveland, CO

Region 10 includes the following states Arizona, Colorado, New Mexico, Utah and Wyoming

Creekside Veterinary Services

Region 11
Veterinarian of the Year, Creekside Veterinary Services, REINS California, Fallbrook, CA

Region 11 includes the following states: California, Hawaii and Nevada; and Asia and Pacific

Congratulations to the 2021 PATH Intl. Veterinarian of the Year Award Winners, and we will be excited to announce the National Veterinarian of the Year in October as we celebrate all the region winners.

Thank you as always to American Regent Animal Health/maker of Adequan® for their continued support and sponsorship of this award that recognizes the best veterinarians in equine-assisted services.

About PATH Intl.:
The Professional Association of Therapeutic Horsemanship International® (PATH Intl.®) was formed in 1969 to promote safety and optimal outcomes in equine-assisted services (EAS) for individuals with special needs. At nearly 750 member centers, more than 66,000 children and adults, including 6,200 veterans, may find improved health, wellness and a sense of pride, independence and fun through involvement with horses. Therapeutic horsemanship at member centers may include hippotherapy, equine-facilitated mental health, driving, interactive vaulting, trail riding, competition, groundwork and stable management. Through a wide variety of educational resources, the association helps individuals start and maintain successful EAS programs. There are nearly 62,500 volunteers, 5,011 instructors, 7,800 equines and thousands of contributors from all over the world helping people at PATH Intl. Member Centers.

About American Regent Animal Health
American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan® (polysulfated glycosaminoglycan). The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for over three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified American Regent portfolio. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.

For more information, contact:
Cher Smith, Communications Specialist
(800) 369-7433, ext. 123
csmith@pathintl.org

PP-AI-US-0516 09/2021


SEPTEMBER, 2021
20
SEP
American Regent Animal Health Becomes Official Sponsor of World Equestrian Center
Ocala, FL – September 20, 2021 – World Equestrian Center welcomes American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan), to its family of official sponsors at World Equestrian Center - Ocala.

American Regent Animal Health Becomes Official Sponsor of World Equestrian Center
Maker of Adequan® supports Ocala venue as exclusive joint health partner

WEC Ocala

Ocala, FL – September 20, 2021 – World Equestrian Center welcomes American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan), to its family of official sponsors at World Equestrian Center - Ocala.

"Adequan® has a 30-year legacy of supporting horses and riders, and we’re excited to build on that tradition through our new partnership with the World Equestrian Center in Ocala," said Andy Ferrigno, Senior Director of Sales and Marketing for American Regent Animal Health. "WEC and Adequan both champion athletes at multiple levels and in multiple disciplines. We look forward to working together to provide riders with new competitive opportunities and to help keep horses moving through all the events at this world-class facility."

World Equestrian Center – Ocala is a year-round equestrian and sports venue with indoor arenas and multipurpose buildings for vendors. Two Expo Centers may host tradeshows and conventions, as well as automobile, art and antique shows and weddings. The expansive facility sits on 378 acres with another 300 in reserve for future expansion.

"At World Equestrian Center, the safety and comfort of our equine athletes is a top priority," said Roby Roberts, World Equestrian Center CEO. "We are grateful for American Regent Animal Health's contributions to our equine athletes, to World Equestrian Center and to equestrian sport."

The partnership with American Regent Animal Health supports WEC in hosting events for equine athletes from across the country and even the world.

About American Regent Animal Health
American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan® (polysulfated glycosaminoglycan). The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for over three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified American Regent portfolio. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.

About World Equestrian Center
World Equestrian Center features two premier equestrian and multidisciplinary venues in Ocala, Florida, and Wilmington, Ohio.

These exclusive facilities comprise state-of-the-art arenas, expansive stadiums, versatile outdoor space, sporting fields and well-appointed exposition centers. An abundance of lodging options and luxury accommodations are conveniently located on-site, along with shopping and dining throughout each property.

Dedicated to offering great sport and fun in a family-friendly environment, World Equestrian Center promises an unparalleled experience for exhibitors, spectators, vendors, sponsors and retailers built on three core values: Quality. Class. Distinction.

Learn more at: wec.net

Media Contact:
Candace FitzGerald
candace.fitzgerald@wec.net
603.738.2788

PP-AI-US-0705 08/2021


AUGUST, 2021
11
AUG
Adequan® Extends Partnership with AQHA
Amarillo, TX – August 11, 2021 – The American Quarter Horse Association is proud to announce that the
11-year partnership with American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan) will continue through 2022. American Regent Animal Health is an AQHA official animal health care manufacturer and Adequan® is AQHA’s official equine joint therapy provider.

Adequan® Extends Partnership with AQHA
AQHA announces Adequan® will continue to be title sponsor of marquis events.

AQHA Woman Riding Horse

Amarillo, TX – August 11, 2021 – The American Quarter Horse Association is proud to announce that the 11-year partnership with American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan) will continue through 2022. American Regent Animal Health is an AQHA official animal health care manufacturer and Adequan® is AQHA’s official equine joint therapy provider.

“AQHA members want the best for their horses, whether they are competing in the performance arena, working on a ranch or riding on the trail,” said Patty Tiberg, AQHA chief marketing and business development officer. “Adequan® is dedicated to the well-being of our equine partners so horses can enjoy all aspects of being a part of AQHA.”

Adequan® is passionate about the American Quarter Horse. Whether AQHA members are involved with pleasure horses, racehorses, performance horses or working horses, Adequan® can be an asset to the team.

“Veterinarians have recommended Adequan® for over 30 years, and we’re pleased that legacy has supported American Quarter Horses,” said Andy Ferrigno, Senior Director of Sales and Marketing for American Regent Animal Health. “We look forward to helping keep AQHA horses and riders moving through everything from walks around the barn to elite competitions.”

Adequan® is the title sponsor of the Adequan® Level 2 Championships; the AQHA Select World Championship Show, presented by Adequan® (polysulfated glycosaminoglycan); Adequan® Level 2 Year-End High-Point awards; Adequan® Derby Challenge; and also supports other AQHA programs such as the Farnam AQHA World Championship Show, Built Ford Tough AQHYA World Championship Show, AQHA Versatility Ranch Horse World Championship Show, Nutrena AQHA Level 1 Championships, regional AQHA Level 2 classes and Bank of America Racing Challenge.

For more information about Adequan® and other AQHA corporate partners, visit www.aqha.com/partners.

AQHA News and information is a service of the American Quarter Horse Association. For more news and information, follow @AQHA on Twitter and visit www.aqha.com/news.

About American Regent Animal Health
American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan® (polysulfated glycosaminoglycan). The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for over three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified American Regent portfolio. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.

PP-AI-US-0676 06/21


JULY, 2021
21
JUL
Adequan® Continues Support of Desert International Horse Park During 2021/2022 Season
Thermal, CA – July 21, 2021 – American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan), has renewed its Platinum-level sponsorship of the Desert International Horse Park (DIHP) and will continue its support of hunter/jumper and dressage events at the West Coast venue during the 2020-2021 competition season that runs from October through April in Thermal, California.

Adequan® Continues Support of Desert International Horse Park During 2021/2022 Season

For Immediate Release:

Thermal, CA – July 21, 2021 – American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan), has renewed its Platinum-level sponsorship of the Desert International Horse Park (DIHP) and will continue its support of hunter/jumper and dressage events at the West Coast venue during the 2020-2021 competition season that runs from October through April in Thermal, California.

"Adequan shares the same love and commitment to horse sport that we do," said Chris Mayone, VP of Sponsorship at the Desert International Horse Park. "We are thrilled to have Adequan as a dedicated partner at DIHP, and we look forward to expanding our partnership with Adequan during this exciting season of growth for us."

Highlighting the 2021/2022 partnership, Adequan will be the title sponsor of the Desert Dressage Series running this fall with multiple weeks of FEI World Cup™ Final qualifying dressage. To view the complete Desert Dressage Series schedule, CLICK HERE.

During the celebrated hunter/jumper events at DIHP, Adequan will continue its longstanding support of horse sport on the West Coast during the National Sunshine Series, Desert Holiday Series and Desert Circuit. Additionally, Adequan will sponsor CSI2* competition during the all- new Major League Show Jumping series that will make two stops at DIHP in December during Desert Holiday. To view the complete DIHP 2021/2022 schedule, CLICK HERE.

“For 30 years, Adequan has supported horses and riders of every discipline, and we are excited to continue that legacy at DIHP,” said Andy Ferrigno, Senior Director of Sales and Marketing for American Regent Animal Health. “We look forward to helping keep horses moving through this competition season.”

Mark your calendars and spend the 2021/2022 competition season at DIHP. Official prize lists and entry information will be released this summer. Keep up to date with the news and updates on the National Sunshine Series and Major League Show Jumping events at the Desert International Horse Park by visiting Deserthorsepark.com.

Follow us on Facebook and Instagram @deserthorsepark.

To learn about sponsorship opportunities at DIHP, CLICK HERE.

About American Regent Animal Health
American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan® (polysulfated glycosaminoglycan). The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for over three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified American Regent portfolio. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.

About the Desert International Horse Park
With nearly 1.5 million square feet of competition and riding space, the Desert International Horse Park is one of the largest equestrian facilities in North America. Offering multiple weeks of world-class equestrian competition from October through March, the facility is a destination location for thousands of equestrians, their horses, family and friends for several months annually. Competitors from all over the world travel to Thermal, CA to not only compete but to enjoy everything the desert has to offer.

PP-AI-US-0676 06/21


MAY, 2021
10
MAY
Adequan® Renews Sponsorship of Young Adult Brentina Cup and Junior Dressage Championships for 2021
Lexington, KY – American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan), has renewed its title sponsorship of the Adequan® USEF Junior Dressage National Championship and the Adequan® USEF Young Adult Brentina Cup Dressage National Championship.

Adequan® Renews Sponsorship of Young Adult Brentina Cup and Junior Dressage Championships for 2021

Lexington, KY – American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan), has renewed its title sponsorship of the Adequan® USEF Junior Dressage National Championship and the Adequan® USEF Young Adult Brentina Cup Dressage National Championship.

These prestigious championships are part of the U.S. Dressage Festival of Champions, which will be held August 24-29, 2021, at HITS Chicago at Lamplight Equestrian Center and streamed live on USEF Network.

“Adequan® has supported horses and riders for more than 30 years, and we are pleased to continue that legacy,” said Andy Ferrigno, Senior Director of Sales and Marketing for American Regent Animal Health. “We look forward to playing a role in helping dedicated riders develop into elite athletes.”

Both championships spotlight talented up-and-coming athletes in American dressage. The Adequan USEF Young Adult Brentina Cup Championship is an invitational event for riders ages 16-25 competing at FEI Intermediaire II and Developing Grand Prix. The Adequan USEF Junior Dressage National Championship is for riders ages 14-18 competing in the FEI Junior Rider tests.

“We’re looking forward to a phenomenal week of dressage at the 2021 U.S. Dressage Festival of Champions,” said US Equestrian CEO Bill Moroney. “The Adequan USEF Young Adult Brentina Cup and Junior Dressage National Championships are an important component of US Equestrian’s dressage program and an inspiration to aspiring dressage athletes. American Regent Animal Health’s sponsorship makes these championships possible, and we’re thrilled to have Adequan’s continued support.”.

About American Regent Animal Health
American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan® (polysulfated glycosaminoglycan). The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for nearly three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified portfolio. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.

PP-AI-US-0607 04/2021


APR, 2021
27
APR
Adequan® Renews Sponsorship of USEF Junior Hunter Championships for 2021
Lexington, KY – American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan), has renewed its title sponsorship of the USEF Junior Hunter National Championships for 2021 and the live stream of these competitions on USEF Network.

Adequan® Renews Sponsorship of USEF Junior Hunter Championships for 2021

Lexington, KY – American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan), has renewed its title sponsorship of the USEF Junior Hunter National Championships for 2021 and the live stream of these competitions on USEF Network.

The Adequan/USEF Junior Hunter National Championships consist of an East Coast and a West Coast final. The East Coast championship is scheduled for July 12-14 at Brandywine Horse Shows in Devon, Pa. The West Coast championship will be held at the Sonoma Horse Park in Petaluma, Calif., July 20-21.

“For more than 30 years, Adequan® has supported horses and riders of all levels,” says Andy Ferrigno, Senior Director of Sales and Marketing for American Regent Animal Health. “We are pleased to support these events featuring young riders on their way to becoming elite athletes.”

Horse-and-rider combinations at the championships compete at the 3’6” and 3’3” fence heights, completing a Classic Round, Under Saddle, and Handy Hunter phases on their quest for one of the most prestigious titles in the hunter discipline.

“The Adequan/USEF Junior Hunter Championships are always a highlight of the competition calendar,” said Bill Moroney, CEO of US Equestrian. “We’re so pleased to have Adequan’s continued support in making both the East Coast and West Coast championships a success year after year. We look forward to welcoming our youth hunter riders to the finals!”

Click here to learn more about the USEF Junior Hunter National Championships.

About American Regent Animal Health
American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan® (polysulfated glycosaminoglycan). The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for nearly three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified portfolio. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.

PP-AI-US-0606 04/2021


27
APR
Adequan® Renews Partnership with the USEA
Shirley, NY – The United States Eventing Association (USEA) is thrilled to announce the renewed partnership with longtime supporter American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan). Adequan® will return as “The Official Joint Therapy Treatment of the USEA,” the Title Sponsor of the $60,000 Adequan® USEA Advanced Final, and a Contributing Level Sponsor of the USEA American Eventing Championships (AEC).

Adequan® Renews Partnership with the USEA

Adequan® returns as The Official Joint Therapy Treatment of the USEA and Title Sponsor of the $60,000 Adequan® USEA Advanced Final.

Shirley, NY – The United States Eventing Association (USEA) is thrilled to announce the renewed partnership with longtime supporter American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan). Adequan® will return as “The Official Joint Therapy Treatment of the USEA,” the Title Sponsor of the $60,000 Adequan® USEA Advanced Final, and a Contributing Level Sponsor of the USEA American Eventing Championships (AEC).

“For over 15 years Adequan® has supported our horses and riders,” said USEA CEO Rob Burk. “Adequan® continues to invest in U.S. Eventing and they recently increased their support by offering unparalleled prize money in the Adequan® USEA Advanced Final. We are proud to have Adequan® as ‘The Official Joint Therapy of the USEA’ and we are very thankful for everything they do for the eventing community.”

As the Title Sponsor of the Adequan® USEA Advanced Final, Adequan® will generously provide $60,000 in prize money to the top finishers. The $60,000 Adequan® USEA Advanced Final will take place during the 2021 AEC on August 31 - September 5, 2021 at the Kentucky Horse Park in Lexington, Kentucky. As a Contributing Level Sponsor of the AEC, Adequan® will also provide prizes for every AEC division.

“We’re excited to continue partnering with USEA to help keep horses moving with Adequan® i.m.,” said Andy Ferrigno, Senior Director of Sales and Marketing for American Regent Animal Health. “We’re looking forward to another season of competition and camaraderie.”

About the $60,000 Adequan® USEA Advanced Final
The $60,000 Adequan® USEA Advanced Final will take place at the 2021 USEA American Eventing Championships presented by Nutrena Feeds at the Kentucky Horse Park in Lexington, Kentucky, August 31 – September 5, 2021. Thanks to Adequan’s amazing support, the Adequan® USEA Advanced Final will bring together the country’s top rides to vie for $60,000 in prize money and the title of Adequan® Champion. To qualify for the $60,000 Adequan® USEA Advanced Final at the AEC in 2021, competitors will need to complete a minimum of two events without cross-country jump penalties at any USEA recognized Advanced horse trials, CCI4*-S, CCI4*-L , or CCI5*-L . The qualifying period for the 2021 AEC is May 25, 2020 through August 23, 2021. Click here to learn more about the $60,000 Adequan® USEA Advanced Final.

About American Regent Animal Health
American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan® (polysulfated glycosaminoglycan). The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for nearly three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified portfolio. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.

PP-AI-US-0633 04/2021


21
APR
US Equestrian Announces Adequan® as Title Sponsor of the New USEF Eventing Youth Team Challenge
Lexington, KY – US Equestrian is pleased to welcome Adequan® i.m. (polysulfated glycosaminoglycan) as the title sponsor of the Adequan® USEF Eventing Youth Team Challenge. The Youth Team Challenge is a new program for 2021 and is open to eventing athletes between the FEI ages of 14 and 25 at the CCI1*, CCI2*, and CCI3* levels. Participants will have the opportunity to experience competing as part of a team and representing their region.

US Equestrian Announces Adequan® as Title Sponsor of the New USEF Eventing Youth Team Challenge

Lexington, KY– US Equestrian is pleased to welcome Adequan® i.m. (polysulfated glycosaminoglycan) as the title sponsor of the Adequan® USEF Eventing Youth Team Challenge. The Youth Team Challenge is a new program for 2021 and is open to eventing athletes between the FEI ages of 14 and 25 at the CCI1*, CCI2*, and CCI3* levels. Participants will have the opportunity to experience competing as part of a team and representing their region.

“Adequan® has supported horses and riders for more than 30 years, and we are excited to continue that legacy,” said Andy Ferrigno, Senior Director of Sales and Marketing for American Regent Animal Health. “The athletes involved in this new program will shape the future of eventing and we look forward to moving ahead with them.”

The Adequan® USEF Eventing Youth Team Challenge is modeled after the FEI Eventing Nations Cup series and includes a series of competitions at events across the country. The series will conclude in the fall with the West Coast final at Galway Downs International in Temeculah, Calif., and the East Coast final at the Tryon International Three-Day Event in Mill Spring, N.C.

“Gaining team experience was integral in my ability to put forward the best performances to secure medals when it mattered most,” said Leslie Law, USEF Development and Emerging Athlete Coach. “We invite U.S. youth athletes to participate in the inaugural USEF Eventing Youth Team Challenge season and become a part of creating sustainable success on the world stage for the U.S.”

Learn more about the Adequan® USEF Eventing Youth Team Challenge here.

About American Regent Animal Health
American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan® (polysulfated glycosaminoglycan). The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for nearly three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified portfolio. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.

PP-AI-US-0601 02/2021


21
APR
Adequan® Continues as Official Joint Therapy of US Equestrian and Sponsor of U.S. Para Dressage Team, USEF Para Dressage National Championship
Lexington, KY – American Regent Animal Health, manufacturer of Adequan® i.m. (polysulfated glycosaminoglycan), will continue its longtime support of US Equestrian through the 2021 competition season. Adequan continues as the Official Joint Therapy of US Equestrian and remains the title sponsor of the USEF Para Dressage National Championship and the U.S. Para Dressage Team.

Adequan® Continues as Official Joint Therapy of US Equestrian and Sponsor of U.S. Para Dressage Team, USEF Para Dressage National Championship

Lexington, KY– American Regent Animal Health, manufacturer of Adequan® i.m. (polysulfated glycosaminoglycan), will continue its longtime support of US Equestrian through the 2021 competition season. Adequan continues as the Official Joint Therapy of US Equestrian and remains the title sponsor of the USEF Para Dressage National Championship and the U.S. Para Dressage Team.

The Adequan U.S. Para Dressage Team is currently the top team on the FEI Para Dressage World Team Ranking List. This summer, they will travel to Tokyo to compete for gold at the 2021 Paralympics.

“With a 30-year legacy of supporting horses and riders, the Adequan® team understands the dedication required to reach this level,” said Andy Ferrigno, Senior Director of Sales and Marketing for American Regent Animal Health. “We are pleased to contribute to the continued success of both individual riders and the Para Dressage Team.”

“We value American Regent’s continued support of US Equestrian and our elite athletes,” said Bill Moroney, CEO of US Equestrian. “We’re beyond excited about the future of our U.S. Para Dressage Team as they continue to raise the bar of excellence on the global stage. Adequan’s sponsorship of the team and of the Adequan/USEF Para Dressage National Championship ensures that our athletes have the opportunity to shine at home and in international competition.”

The 2021 Adequan/USEF Para Dressage National Championship will take place October 28-30 at the Tryon International Equestrian Center in Mill Spring, N.C., in conjunction with the Tryon Fall Dressage 3 CDI-W.

Click here to learn more about USEF Para Dressage Programs and the U.S. Para Dressage Team.

About American Regent Animal Health
American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan® (polysulfated glycosaminoglycan). The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for nearly three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified portfolio. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.

PP-AI-US-0605 04/2021


FEB, 2021
3
FEB
American Regent Animal Health Convenes Expert Panel to Provide Exclusive Insights on DJD
Shirley, NY – American Regent Animal Health, in partnership with EquiManagement, publishes insights from a panel discussion among eight veterinary practitioners to better understand how to help horses affected by degenerative joint disease (DJD). The panel comprises a cross-section of equine practitioners, including a recent graduate in private practice, leading imaging and lameness practitioners, and researchers and surgeons.

American Regent Animal Health Convenes Expert Panel to Provide Exclusive Insights on DJD

Shirley, NY – American Regent Animal Health, in partnership with EquiManagement, publishes insights from a panel discussion among eight veterinary practitioners to better understand how to help horses affected by degenerative joint disease (DJD). The panel comprises a cross-section of equine practitioners, including a recent graduate in private practice, leading imaging and lameness practitioners, and researchers and surgeons.

American Regent Animal Health, manufacturer of Adequan® i.m. (polysulfated glycosaminoglycan), enlisted EquiManagement to moderate the half-day conversation and curate the key takeaways, which address:

  • DJD incidence and diagnostic improvements
  • The horse owner’s role in recognizing DJD
  • Challenges with DJD supplements
  • DJD treatment options
  • Tips for clear communication between veterinarians and horse owners

Panelists agree more horses are being diagnosed with DJD. More horses are working later into their lives, making DJD a larger issue for the equine population, including horses ranging from elite competitors to “play day” mounts. The insights from the discussion may help practicing equine veterinarians successfully manage DJD in patients.

A few highlights from the expert comments:

  • "I do think in those young, hardworking, active athletes with that big push in their 3-year-old year that the incidence [of DJD] has probably gone up, especially in stifles and hocks." -Dr. Chris Kawcak
  • "First of all, one size does not fit all [in DJD treatment]. There's no cookbook [in DJD treatment]." -Dr. Rick Mitchell
  • "I try to talk to clients, telling them I feel it's a bigger bang for your buck if you go with the intramuscular Adequan [than unproven supplements]." -Dr. Robin Dabareiner

Click here to access the entirety of the panel’s exclusive insights.

INDICATIONS
For the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.

IMPORTANT SAFETY INFORMATION
There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan. Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For more information and Full Prescribing Information, www.adequan.com.

About American Regent Animal Health
American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan® (polysulfated glycosaminoglycan). The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for nearly three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified portfolio. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.

PP-AI-US-0600 02/2021



SEP, 2020
20
SEP
Roll Out the Red Carpet for the 2020 PATH Intl. Veterinarian Award Winners
Denver, CO – The Professional Association of Therapeutic Horsemanship (PATH Intl.) takes great pride in the exceptional veterinarians who serve at PATH Intl. Member Centers and the quality of life for the equines that partner with humans in equine-assisted activities and therapies (EAAT). PATH Intl. is pleased to announce the 2020 PATH Intl. Veterinarian Award in its 11 regions and the national award winner, sponsored by American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan).

For more information, contact:
Cher Smith, Communications Coordinator
(800) 369-7433, ext. 123
csmith@pathintl.org

Roll Out the Red Carpet for the 2020 PATH Intl. Veterinarian Award Winners

Denver, CO – The Professional Association of Therapeutic Horsemanship (PATH Intl.) takes great pride in the exceptional veterinarians who serve at PATH Intl. Member Centers and the quality of life for the equines that partner with humans in equine-assisted activities and therapies (EAAT). PATH Intl. is pleased to announce the 2020 PATH Intl. Veterinarian Award in its 11 regions and the national award winner, sponsored by American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan).

In previous years, PATH Intl. has celebrated the region winners at regional conferences and the national winners at the PATH Intl. Conference awards luncheon. Although this year the national conference and most of the regional conferences were postponed, the winners of these awards deserve recognition of their achievements. PATH Intl. and American Regent Animal Health offer their congratulations and accolades to these winners. In acknowledgement, American Regent Animal Health is providing five boxes of Adequan® i.m. to each regional recipient and 20 boxes of Adequan® i.m. to the national recipient.

(PATH Intl. Premier Accredited Centers are shown in italics.)

2020 PATH Intl. Regional Winners

Region 1
Veterinarian of the Year: Dr. Robert Baratt, High Hopes Therapeutic Riding, Inc., Old Lyme, CT

Region 1 includes the following states: Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont; and the Canadian provinces: New Brunswick, Newfoundland, Nova Scotia, Prince Edward Island and Quebec

Region 2
Veterinarian of the Year, Dr. Elden Klayman, Chariot Riders, Manchester, NJ

Region 2 includes the following states: Delaware, Maryland, New Jersey, New York, Pennsylvania and Washington, DC; and Scandinavia, Europe, Middle East

Region 3
Veterinarian of the Year, Dr. John Sanginario, EQUI-KIDS, Virginia Beach, VA

Region 3 includes North Carolina, South Carolina, Virginia and West Virginia

Region 4
Veterinarian of the Year, Dr. Sasha Hill, Fieldstone Farm Therapeutic Riding Center, Chagrin Falls, OH

Region 4 includes the following states: Indiana, Kentucky, Michigan, Ohio; and the Canadian Province of Ontario

Region 5
Veterinarian of the Year, Dr. Scott Swerdlin, Vinceremos Therapeutic Riding Center, Loxahatchee, FL

Region 5 includes Alabama, Florida, Georgia, Mississippi, Puerto Rico, Tennessee and Africa

Region 6
Veterinarian of the Year, Dr. Margaret Fauver, HorseSense, La Crosse, WI

Region 6 includes the following states: Minnesota, North Dakota, South Dakota and Wisconsin; and the Canadian Provinces of Manitoba and Saskatchewan

Region 7
Veterinarian of the Year, Dr. Ashley Wegmann, New Kingdom Trailriders, Sherrard, IL

Region 7 includes Illinois, Iowa, Kansas, Missouri and Nebraska

Region 8
Veterinarian of the Year, Dr. Kenton Arnold, Equest, Dallas, TX

Region 8 includes the following states: Arkansas, Louisiana, Oklahoma and Texas; and Mexico, Central America and South America

Region 9
Veterinarian of the Year, Dr. Cierra Dedeker,Ride for Joy Therapeutic Riding Program, Caldwell, ID

Region 9 includes the following states: Alaska, Idaho, Montana, Oregon and Washington State; and the Canadian provinces of Alberta and British Columbia

Region 10
Veterinarian of the Year, Dr. Judy Morris, StableStrides, Elbert, CO

Region 10 includes Arizona, Colorado, New Mexico, Utah and Wyoming

Region 11
Veterinarian of the Year, Dr. Kelly Zeytoonian, BOK Ranch, Woodside, CA

Region 11 includes the following states: California, Hawaii and Nevada; and Asia and Pacific

And the National Winner of the 2020 PATH Intl. Veterinarian of the Year is Ashley Wegmann.

Ashley Wegmann, who is described as hard-working and compassionate in all she does, takes time out of her busy schedule to volunteer her time to care for the horses at New Kingdom Trailriders in Sherrard, IL. She is currently a veterinarian at DeWitt Veterinary Clinic where she cares for animals of all shapes and sizes.

Congratulations to the 2020 PATH Intl. Veterinarian of the Year Award Winners!

-30-

About PATH Intl.:
The Professional Association of Therapeutic Horsemanship International® (PATH Intl.®) was formed in 1969 to promote safety and optimal outcomes in equine-assisted activities and therapies (EAAT) for individuals with special needs. At 881 member centers, more than 66,000 children and adults, including 6,200 veterans, may find improved health, wellness and a sense of pride, independence and fun through involvement with horses. Therapeutic horsemanship at member centers may include hippotherapy, equine-facilitated mental health, driving, interactive vaulting, trail riding, competition, ground work and stable management. Through a wide variety of educational resources, the association helps individuals start and maintain successful EAAT programs. There are nearly 62,500 volunteers, 5,011 instructors, 7,800 equines and thousands of contributors from all over the world helping people at PATH Intl. Member Centers.

About American Regent Animal Health:
American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan® (polysulfated glycosaminoglycan). The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for nearly three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified portfolio. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.

PP-AI-US-0506 9/2020



JUL, 2020
15
JUL
New Podcast Gives a Peek Behind the Barn Door of Legendary Equestrians
Melville, NY – American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan), announces the launch of "Stories in Stride," a podcast that provides a glimpse into the lives and journeys of exceptional equestrians and equine professionals. Hosted by Allyn Mann, Director of Strategic Partnerships for American Regent Animal Health, the podcast transcends disciplines to inspire and uplift everyone who shares a love of the horse.

New Podcast Gives a Peek Behind the Barn Door of Legendary Equestrians
During this time apart, “Stories in Stride” brings the horse community together through first-person accounts of success, disappointment, perseverance and hope.

Melville, NY – American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan), announces the launch of "Stories in Stride," a podcast that provides a glimpse into the lives and journeys of exceptional equestrians and equine professionals. Hosted by Allyn Mann, Director of Strategic Partnerships for American Regent Animal Health, the podcast transcends disciplines to inspire and uplift everyone who shares a love of the horse.

"The equine community is rich with amazing individuals whose stories are humbling, humorous and invigorating," Mann says. "It’s a privilege to bring them to light as a way of honoring history, addressing current challenges and highlighting an optimistic future we can shape together through our joint devotion to horses and equine sport."

Each "Stories in Stride" episode features a one-on-one conversation with an elite rider, trainer or veterinarian, including:

  • Boyd Martin, Olympic eventer
  • Bob Avila, Quarter Horse trainer
  • Rebecca Hart, Paralympic equestrian
  • JD Yates, performance horse trainer and team roper
  • Richard Mitchell, DVM, MRCVS, Dipl. ACVSMR, sport horse veterinarian and champion
  • And many more

The initial installments of "Stories in Stride" are available now, and new episodes will be released throughout the year. "Stories in Stride" can be accessed from Apple Podcasts, Google Podcasts and Spotify or your favorite podcast platform.

About American Regent Animal Health
American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan®. The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for nearly three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified portfolio under the American Regent brand. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.

PP-AI-US-0506 7/2020





Let’s stay in touch.

Be the first to hear about important news and product information!
First, select the one that best describes you.
Then we'll take you to our sign-up page.

EQUINE VETERINARY
PROFESSIONAL
HORSE OWNER
AMERICAN REGENT ANIMAL HEALTH
About Us Our Brands
Animal Health Logo